美国食品药品监督管理局（FDA）已批准艾伯维公司旗下爱力根美学部门的Juvéderm® Skinvive产品，用于改善成人颈部外观。该批准标志着这一透明质酸填充剂在美学应用领域获得了新的适应症。
此次获批基于一项关键的临床研究数据，该研究证实了Skinvive在改善颈部皮肤质地和外观方面的有效性与安全性。爱力根美学表示，这一新适应症将为其产品组合提供重要补充，并有望满足市场对颈部年轻化治疗日益增长的需求。
作为艾伯维在医美领域的重要布局，Juvéderm®系列产品此次拓展适应症，进一步巩固了其在全球填充剂市场的领先地位。行业分析师指出，颈部美容正成为医美市场快速增长的细分领域，此次批准可能为爱力根美学带来新的增长动力。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.